Aclaris Gets FDA Nod to Begin Phase 1a/1b Trial of...
Category : Clinical Trial Update 24 April 2025Aclaris Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing novel p...
Clinical Trial Update
Zealand Pharma Begins Phase 2b ZUPREME-2 Trial for...
Category : Clinical Trial Update 24 April 2025Zealand Pharma announces first participant enrolled in Phase 2b ZUPREME-2 trial of petrelintide in p...
Bristol Myers’ Camzyos Phase 3 Trial Fails to Meet...
Category : Clinical Trial Update 17 April 2025Bristol Myers Squibb announced the phase 3 ODYSSEY-HCM trial evaluating Camzyos (mavacamten) for the...
XellSmart's iPSC Cell Therapies for Parkinson’s &...
Category : Clinical Trial Update 17 April 2025In January 2025, the U.S. Food and Drug Administration (FDA) officially approved the Investigational...
Sanofi Advances Respiratory Pipeline with Asthma D...
Category : Clinical Trial Update 16 April 2025Sanofi shared new progress from its mid- to late-stage respiratory pipeline, including preliminary p...
Latest Newsletter Post
-
Zealand Pharma Begins Phase 2b ZUPR..
24 April 2025
-
Gene Solutions and Element Bioscien..
24 April 2025
-
Invivoscribe’s FLT3 ITD MRD Assay A..
24 April 2025
-
Aclaris Gets FDA Nod to Begin Phase..
24 April 2025
-
Roche Gets CE Mark for Chest Pain A..
23 April 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com